References

• References

1. Berkel, J, Holcombe, RF, Middlebrooks, M & Kannan, K (1996). Non-steroidal anti-inflammatory drugs and colorectal cancer. Epidemiol Rev 18: 205–217.
2. Collet, J-P, Sharpe, C, Belzile, E, Boivin, J-F, Hanley, J & Abenhaim, L (1999). Colorectal cancer prevention by nonsteroidal antiinflammatory drugs: effects of dosage and timing. Br J Cancer 80: 00–00.
3. Gann, PH, Manson, JE, Glynn, RJ, Buring, JE & Hennekens, CH (1993). Low-dose aspirin and incidence of colorectal tumors in a randomized trial. J Natl Cancer Inst 85: 1220–1224. | Article | PubMed | ChemPort |
4. Giovannuci, E, Egan, KM, Hunter, DJ, Stampfer, MJ, Colditz, GA, Willett, WC & Speizer, FE (1995). Aspirin and the risk of colorectal cancer in women. N Engl J Med 333: 609–614. | Article | PubMed | ISI | ChemPort |
5. Marnett, LJ (1992). Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res 52: 5575–5589. | PubMed | ISI | ChemPort |
6. Sheng, H, Shao, J, Kirkland, SC, Isakson, P & Coffey, RJ (1997). Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J Clin Invest 99: 2254–2259. | PubMed | ISI | ChemPort |
7. Waddell, WR & Loughrey, RW (1983). Sulindac for polyposis of the colon. J Surg Oncol 24: 83–87. | Article | PubMed | ISI | ChemPort |